Showing results (71-80 of 121) with videos related to
Sort By:
Pageof 13
Surgical Oncology|December 2, 2008
Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 casesCaigang Liu, Ruishan Zhang, Yang Lu, et al.International Journal of Medical Sciences|June 13, 2022
The altering in sensory sensitivity: a current issue of female breast surgeryTong Zhu, Yi Jiang, Ting Liu, et al.International Journal of Biological Sciences|June 19, 2020
PAK4 phosphorylating RUNX1 promotes ERα-positive breast cancer-induced osteolytic bone destructionLina Tang, Yunling Gao, Yongqi Song, et al.Journal of Cancer|November 19, 2019
Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast CancerXudong Zhu, Jinqi Xue, Xi Gu, et al.Chemico-Biological Interactions|December 17, 2017
Traditional herbal medicine-derived sulforaphene promotes mitophagic cell death in lymphoma cells through CRM1-mediated p62/SQSTM1 accumulation and AMPK activationHaina Wang, Fuqiang Wang, Sijin Wu, et al.International Journal of Medical Sciences|October 6, 2025
Erratum: CEMIP as a potential biomarker and therapeutic target for breast cancer patients: ErratumJinqi Xue, Xudong Zhu, Xinbo Qiao, et al.Molecular and Clinical Oncology|March 21, 2014
Clinical characteristics and prognostic analysis of triple-negative breast cancer patientsNa Yuan, Min Meng, Caigang Liu, et al.Surgical Oncology|October 29, 2008
Impact of total retrieved lymph nodes on staging and survival of patients with gastric cancer invading the subserosaCaigang Liu, Yang Lu, Zhu Jun, et al.Plos One|September 26, 2014
Galectin-3 as a marker and potential therapeutic target in breast cancerHao Zhang, Minna Luo, Xi Liang, et al.Plos One|April 17, 2020
Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast CancerHao Zhang, Minna Luo, Xi Liang, et al.Pageof 13